Literature DB >> 27896075

The value of neuroimaging in the assessment and follow-up of early-onset methylmalonic aciduria and homocystinuria.

Fernando M de Benedictis1, Diletta de Benedictis1.   

Abstract

Entities:  

Year:  2014        PMID: 27896075      PMCID: PMC5121300          DOI: 10.1016/j.ymgmr.2013.11.003

Source DB:  PubMed          Journal:  Mol Genet Metab Rep        ISSN: 2214-4269


× No keyword cloud information.
Sir, In their prospective neurodevelopmental evaluation of children with combined methylmalonic acidemia and homocystinuria, cobalamin C type (MMAHCC), Weisfeld-Adams et al. [1] obtained a magnetic resonance imaging and spectroscopy (MRI/MRS) of the brain. While the authors report a range of MRI brain abnormalities similar to previously published series, MR spectra were found to be normal in all subjects. In a 2-month old patient with MMAHCC seen in our Centre, MRS showed a reduction in the main metabolite peaks in frontal white matter, with N-acetylaspartate peak and N-acetylaspartate/creatine ratio reduction. These findings, which indicate diffuse neuronal damage, were confirmed at the MRS imaging follow up, two years later. Abnormal MRS brain imaging in patients with MMAHCC has been reported by other authors and are likely due to remethylation defects [2], [3]. Further studies which are explicitly addressed at dynamic evaluation of MRS in children with MMAHCC may better explain the role of impaired methyl group metabolism in disease-related complications.
  3 in total

1.  MRI and 1H-MRS findings in early-onset cobalamin C/D defect.

Authors:  D Longo; G Fariello; C Dionisi-Vici; V Cannatà; S Boenzi; E Genovese; F Deodato
Journal:  Neuropediatrics       Date:  2005-12       Impact factor: 1.947

2.  Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type.

Authors:  James D Weisfeld-Adams; H Allison Bender; Anna Miley-Åkerstedt; Tamiesha Frempong; Nina L Schrager; Keyur Patel; Thomas P Naidich; Victoria Stein; Jessica Spat; Stephanie Towns; Melissa P Wasserstein; Inga Peter; Yitzchak Frank; George A Diaz
Journal:  Mol Genet Metab       Date:  2013-07-25       Impact factor: 4.797

3.  Reduced brain choline in homocystinuria due to remethylation defects.

Authors:  F-G Debray; Y Boulanger; A Khiat; J-C Decarie; J Orquin; M-S Roy; A Lortie; F Ramos; N M Verhoeven; E Struys; H J Blom; C Jakobs; E Levy; G A Mitchell; M Lambert
Journal:  Neurology       Date:  2008-07-01       Impact factor: 9.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.